Cuts FY adj EPS guidance to 2.80-2.95 usd (Il Sole 24 Ore Radiocor) - New York, 27 Jun - Walgreens cuts its fiscal 2024 adjusted EPS guidance to 2.80-2.95 dollars "reflecting challenging pharmacy industry trends and a worse-than-expected US consumer environment." The company also released an update of its strategic review.

It said that it is finalizing a "significant multiyear footprint optimization program to close certain underperforming US stores." Walgreens is also launching US Retail Pharmacy action plan to "invest in and deliver an improved customer and patient experience across channels." It is aligning the US Pharmacy and Healthcare organizations "for enhanced go-to-market capabilities." It is also "simplifying and focusing" the US Healthcare portfolio.

AAA-Web

(RADIOCOR) 27-06-24 13:38:50 (0387) 5 NNNN